Creative Planning Bristol Myers Squibb CO Call Options Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $23,990 - $27,200	500 New	500 $27,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $58,096 - $63,984	-800 Reduced 80.0%	200 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $43,036 - $51,604	700 Added 233.33%	1,000 $5,000
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $8,554 - $10,142	-200 Reduced 40.0%	300 $2,000
Q2 2019 Jul 26, 2019	SELL	$44.62 - $49.34 $40,158 - $44,406	-900 Reduced 64.29%	500 $1,000
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $22,076 - $24,900	400 Added 40.0%	1,400 $5,000
Q1 2018 Apr 18, 2018	BUY	$59.92 - $68.98 $59,920 - $68,980	1,000 New	1,000 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.